Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APERITIF: Rivaroxaban for LV Thrombus Prevention in AMI
NCT05077683Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2021
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rivaroxaban in left ventricular thrombus (LVT), sponsored by Assistance publique - Hôpitaux de Paris. Started Oct 2021; status: completed.
02
Drugs
rivaroxaban
03
Conditions
left ventricular thrombus (LVT)
Beyond the preview
Go deeper on NCT05077683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05077683.